Capital Flow Monitor · Sponsors · CIK 2116194
AirNexis Therapeutics, Inc.
1001 PAGE MILL ROAD, PALO ALTO, CA, 94304 · (619) 604-7904
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$200.0M
Sold
$62.0M
% sold
31.0%
Investors
13
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-09 | D ·current | 506(b) | $200.0M | $62.0M | 31.0% | 13 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Maria Fardis — Executive Officer / Director, Palo Alto, CA
1 other raise
- Quanta Therapeutics, Inc. $76.2M of $89.1M · 85.5%
-
Anna Chen — Director, Palo Alto, CA
1 other raise
- Eyconis, Inc. $25.0M of $89.8M · 27.9%
-
Evan Caplan — Director, Palo Alto, CA
2 other raises
- Aer Therapeutics, Inc. $3.0M of $3.0M · 100.0%
- Renasant Bio, Inc. $30.0M of $30.0M · 100.0%
-
Colin Walsh — Director, Palo Alto, CA
1 other raise
- Varo Money, Inc. $123.9M of $155.0M · 79.9%
-
Jill Carroll — Director, Palo Alto, CA
1 other raise
- Odyssey Therapeutics, Inc. $214.0M of $214.0M · 100.0%
- James Li — Executive Officer / Director, Palo Alto, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.